Central nervous system immune reconstitution inflammatory syndrome after ibrutinib therapy for Richter transformation.
a Department of Haematology , Peter MacCallum Cancer Centre , Melbourne , Australia.
Kah-Lok
KL
Chan
b Department of Pathology , Austin Hospital , Melbourne , Australia.
Julie
J
Lokan
a Department of Haematology , Peter MacCallum Cancer Centre , Melbourne , Australia.|c The University of Melbourne , Melbourne , Australia.
Constantine S
CS
Tam
d Alfred Hospital , Melbourne , Australia.
Thomas Eliot
TE
Lew
a Department of Haematology , Peter MacCallum Cancer Centre , Melbourne , Australia.|c The University of Melbourne , Melbourne , Australia.
H Miles
HM
Prince
D000225:Adenine / Q000031:analogs & derivatives; D002471:Cell Transformation, Neoplastic / Q000187:drug effects* / Q000473:pathology; D002490:Central Nervous System / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000150:complications*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy; D018655:Lymphocyte Count; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010880:Piperidines; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine